CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net loss	$ (31,137)	$ (10,524)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	12,055	11,966
Equity-based compensation	3,857	479
Paid-in-kind interest added to debt principal		294
Provision for credit losses	653	922
Amortization of deferred financing fees included in interest expense	988	1,046
Loss on disposal of property, plant and equipment	896	289
Mark-to-market adjustments	(2,205)	250
Change in fair value of warrant liabilities	6,272
Foreign currency transactions	907	91
Deferred income tax (benefit) expense	1,881	(3,083)
Other	992
Change in operating assets and liabilities:
Accounts receivable	649	(11,137)
Inventories	(6,874)	(53,663)
Derivative assets and liabilities	693	(10,743)
Prepaid expense and other assets	(8,529)	(14,257)
Accounts payable	(24,080)	37,278
Accrued liabilities and other	7,314	3,818
Net cash used in operating activities	(35,668)	(46,974)
Cash flows from investing activities:
Additions to property, plant and equipment	(55,745)	(15,163)
Additions to intangible assets	(95)	(48)
Acquisition of business, net of cash acquired	(2,392)
Proceeds from sale of property, plant and equipment	57	2,248
Net cash used in investing activities	(58,175)	(12,963)
Cash flows from financing activities:
Payments on debt	(79,795)	(51,665)
Proceeds from debt	156,118	107,423
Proceeds from supply chain financing program	29,026
Payment of debt issuance costs	(2,582)
Net repayments from repurchase agreements	(5,236)
Proceeds from exercise of stock options	63
Proceeds from exercise of Public Warrants	2,632
Payment for purchase of non-controlling interest	(2,000)
Payment for taxes for net share settlement of equity awards	(1,841)	(477)
Net cash provided by financing activities	96,385	55,281
Effect of exchange rate changes on cash	(165)	(29)
Net increase (decrease) in cash and cash equivalents and restricted cash	2,377	(4,685)
Cash and cash equivalents and restricted cash at beginning of period	26,405	22,870
Cash and cash equivalents and restricted cash at end of period	28,782	18,185
Supplemental non-cash investing and financing activities:
Property, plant and equipment acquired but not yet paid	17,958	372
Issuance of common shares related to Public Warrant exercise	3,144
Issuance of common shares related to acquisitions	446
Issuance of common shares related to conversion of Series A Preferred Shares	254
Issuance of common shares related to purchase of non-controlling interest	475
Accretion of convertible preferred shares	$ 341
Accumulating preferred dividends		$ 13,882